Carcinoembryonic Antigen Market Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 - 2025 BY Credence Research

Carcinoembryonic Antigen Market Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 - 2025 BY Credence Research

ID: 1530360
recent pressrelease next pressrelease

(businesspress24) - The latest market report published by Credence Research, Inc. 2023.

Market Insights

According to Quest Diagnostics, CEA is an oncofetal glycoprotein present in the gastrointestinal tract and body fluids of the embryo and fetus. This antigen is also present in certain adult gastrointestinal cells, including the mucosal cells of the colorectum, and small amounts are present in blood. Market experts suggest that key growth drivers assisting the growth of CEA market comprises high prevalence of cancer, mounting global geriatric population base, high demand for minimally invasive diagnostic procedures in cancer and increasing application of CEA for diagnosis at several stages of cancer. In addition, a few factors that assist the overall market growth are growing healthcare expenditure which is boosting the need for efficient diagnostic procedure for cancer and influencing the usage of combination biomarkers.

Browse the full report Carcinoembryonic Antigen (CEA) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016

The global carcinoembryonic antigen (CEA) market is segmented on the basis of application type into ovarian cancer, colorectal cancer, pancreatic cancer, lung cancer, breast cancer, thyroid cancer and other cancers. In base year 2015, colorectal cancer dominated the overall market in terms of revenue. The key factors responsible for growth of CEA market are increase in number of population consuming alcohol, sedentary lifestyle, and high intake of saturated fats in all age groups. Moreover, rising preference for CEA test in cancer diagnosis and management is expected to assist its market growth in the near future.

In base year 2015, North America was observed as the largest CEA market due to high public awareness related to early cancer diagnosis, rising preference for minimally invasive cancer diagnosis tests and sophisticated health care facilities for cancer management. Incessant technological developments followed by new discoveries of specific antigens and biomarkers are anticipated to boost the growth of CEA market testing. The key factors assisting the growth of CEA market comprises aging population, highly accessible technologically advanced healthcare facilities, successful governmental and non-governmental initiatives, and demand for precise diagnostic procedures.

Market Competition Assessment:

The carcinoembryonic antigen (CEA) market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Quest Diagnostics, F. Hoffman LA Roche, Abbott Laboratories, GenWay Biotech Inc., Correlogic Systems, Inc., and Others.

Browse the full report Carcinoembryonic Antigen (CEA) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016

Key Market Movements:

Rising prevalence of cancer is expected to drive the CEA tests market in the near future
Increasing demand for minimally invasive diagnosis methods for cancer
Growing healthcare expenditure in developing countries is assisting the growth of CEA tests
The regulatory framework for approval process has always been the most critical restraining factor in the cancer diagnosis
According to NICE, the specificity in detecting diseases is almost between 30-80% during CEA test for the diagnosis of early colorectal cancer. This test is much more useful in detecting prognosis other than early diagnostic phase, where the specificity is expected to be 65% of detecting diseases
Latest Report

X-Ray Equipment Market

Non-Alcoholic Steatohepatitis Market

Burn Care Market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we


Name: Chris Smith

Designation: Global Sales Manager

Ph: 1-800-361-8290

Email: sales(at)


More information:

Keywords (optional):

Company information / Profile:

PressRelease by


PressContact / Agency:


published by: satyamspot
print pressrelease  send to a friend  

Date: 12/12/2017 - 06:00
Language: English
News-ID 1530360
Character count: 5421
Firma: Credence Research
Ansprechpartner: jayvir singh Feedback to about Pressrelease-id:
Stadt: San Jose
Telefon: 8003618290

Meldungsart: Erfolgsprojekt
Versandart: Veröffentlichung
Freigabedatum: 12/12/2017

Number of hits: 376


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 193
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 50

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.